
FDA Approves PIMJETMI® Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor Merck, a leading science and technology company, announced that the U.S. Food and Drug Administration (FDA) has approved PIMJETMI® (pimicotinib), a once-daily oral colony stimulating factor-1 receptor (CSF-1R) inhibitor,…














